Stay updated on Nivolumab Ipilimumab Neuroendocrine Tumors Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Ipilimumab Neuroendocrine Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Ipilimumab Neuroendocrine Tumors Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page’s footer revision label has been updated from v3.5.2 to v3.5.3, reflecting a new site version rather than a change to the study’s content.
    Difference
    0.1%
    Check dated 2026-04-23T21:53:05.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2, indicating a system update; no study content changes are indicated.
    Difference
    0.1%
    Check dated 2026-04-16T12:14:46.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    45 days ago
    Change Detected
    Summary
    Added Carcinoid tumor to MeSH terms and included a Resources section for Genetic and Rare Diseases Information Center. Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-18T21:56:07.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 of the page framework. The trial-specific content remains unchanged.
    Difference
    0.1%
    Check dated 2026-03-11T18:23:09.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Added a new revision tag 'Revision: v3.4.2'. Removed older maintenance notices including the funding-lapse notice and 'Revision: v3.4.1'.
    Difference
    0.4%
    Check dated 2026-02-11T09:42:36.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding and NIH operations was added, and the page version updated from v3.4.0 to v3.4.1, with no modifications to the study details or core content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T06:55:48.000Z thumbnail image

Stay in the know with updates to Nivolumab Ipilimumab Neuroendocrine Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab Neuroendocrine Tumors Clinical Trial page.